nodes	percent_of_prediction	percent_of_DWPC	metapath
Aminocaproic Acid—AOX1—Methotrexate—lymphatic system cancer	0.621	1	CbGbCtD
Aminocaproic Acid—Thrombosis—Mechlorethamine—lymphatic system cancer	0.0153	0.0403	CcSEcCtD
Aminocaproic Acid—Intracranial pressure increased—Carmustine—lymphatic system cancer	0.0107	0.0283	CcSEcCtD
Aminocaproic Acid—Local reaction—Bleomycin—lymphatic system cancer	0.00927	0.0245	CcSEcCtD
Aminocaproic Acid—Local reaction—Mitoxantrone—lymphatic system cancer	0.00752	0.0199	CcSEcCtD
Aminocaproic Acid—Thrombosis—Carmustine—lymphatic system cancer	0.00633	0.0167	CcSEcCtD
Aminocaproic Acid—Necrosis—Carmustine—lymphatic system cancer	0.0057	0.0151	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Mechlorethamine—lymphatic system cancer	0.00564	0.0149	CcSEcCtD
Aminocaproic Acid—Necrosis—Mitoxantrone—lymphatic system cancer	0.0053	0.014	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Fludarabine—lymphatic system cancer	0.00518	0.0137	CcSEcCtD
Aminocaproic Acid—Tinnitus—Mechlorethamine—lymphatic system cancer	0.00506	0.0134	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Carmustine—lymphatic system cancer	0.00448	0.0118	CcSEcCtD
Aminocaproic Acid—Injection site reaction—Carmustine—lymphatic system cancer	0.00445	0.0118	CcSEcCtD
Aminocaproic Acid—Leukopenia—Mechlorethamine—lymphatic system cancer	0.00423	0.0112	CcSEcCtD
Aminocaproic Acid—Blood urea increased—Mitoxantrone—lymphatic system cancer	0.00393	0.0104	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Mechlorethamine—lymphatic system cancer	0.00385	0.0102	CcSEcCtD
Aminocaproic Acid—Renal failure—Fludarabine—lymphatic system cancer	0.00385	0.0102	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Bleomycin—lymphatic system cancer	0.0038	0.01	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Mechlorethamine—lymphatic system cancer	0.00377	0.00997	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Mitoxantrone—lymphatic system cancer	0.00312	0.00825	CcSEcCtD
Aminocaproic Acid—Leukopenia—Teniposide—lymphatic system cancer	0.00311	0.00823	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Carmustine—lymphatic system cancer	0.00287	0.00757	CcSEcCtD
Aminocaproic Acid—Confusional state—Teniposide—lymphatic system cancer	0.00286	0.00757	CcSEcCtD
Aminocaproic Acid—Oedema—Teniposide—lymphatic system cancer	0.00284	0.0075	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Mechlorethamine—lymphatic system cancer	0.00284	0.0075	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Fludarabine—lymphatic system cancer	0.00284	0.0075	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Teniposide—lymphatic system cancer	0.00278	0.00735	CcSEcCtD
Aminocaproic Acid—Malaise—Fludarabine—lymphatic system cancer	0.00276	0.00729	CcSEcCtD
Aminocaproic Acid—Leukopenia—Fludarabine—lymphatic system cancer	0.00274	0.00723	CcSEcCtD
Aminocaproic Acid—Muscular weakness—Vincristine—lymphatic system cancer	0.00274	0.00723	CcSEcCtD
Aminocaproic Acid—Pruritus—Mechlorethamine—lymphatic system cancer	0.00273	0.0072	CcSEcCtD
Aminocaproic Acid—Hypotension—Teniposide—lymphatic system cancer	0.00265	0.00701	CcSEcCtD
Aminocaproic Acid—Convulsion—Fludarabine—lymphatic system cancer	0.00265	0.007	CcSEcCtD
Aminocaproic Acid—Necrosis—Methotrexate—lymphatic system cancer	0.00264	0.00698	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Mechlorethamine—lymphatic system cancer	0.00264	0.00696	CcSEcCtD
Aminocaproic Acid—Myalgia—Fludarabine—lymphatic system cancer	0.0026	0.00688	CcSEcCtD
Aminocaproic Acid—Discomfort—Fludarabine—lymphatic system cancer	0.00257	0.0068	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Teniposide—lymphatic system cancer	0.00253	0.00669	CcSEcCtD
Aminocaproic Acid—Confusional state—Fludarabine—lymphatic system cancer	0.00252	0.00665	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Fludarabine—lymphatic system cancer	0.0025	0.0066	CcSEcCtD
Aminocaproic Acid—Oedema—Fludarabine—lymphatic system cancer	0.0025	0.0066	CcSEcCtD
Aminocaproic Acid—Renal failure—Carmustine—lymphatic system cancer	0.00246	0.00651	CcSEcCtD
Aminocaproic Acid—Vomiting—Mechlorethamine—lymphatic system cancer	0.00245	0.00647	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Fludarabine—lymphatic system cancer	0.00244	0.00646	CcSEcCtD
Aminocaproic Acid—Rash—Mechlorethamine—lymphatic system cancer	0.00243	0.00642	CcSEcCtD
Aminocaproic Acid—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00243	0.00641	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Teniposide—lymphatic system cancer	0.00234	0.00618	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00232	0.00614	CcSEcCtD
Aminocaproic Acid—Renal failure—Mitoxantrone—lymphatic system cancer	0.00229	0.00605	CcSEcCtD
Aminocaproic Acid—Nausea—Mechlorethamine—lymphatic system cancer	0.00229	0.00605	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00227	0.00601	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Teniposide—lymphatic system cancer	0.00225	0.00593	CcSEcCtD
Aminocaproic Acid—Hallucination—Carmustine—lymphatic system cancer	0.00224	0.00591	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Fludarabine—lymphatic system cancer	0.00223	0.00588	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Mitoxantrone—lymphatic system cancer	0.00217	0.00574	CcSEcCtD
Aminocaproic Acid—Hallucination—Vincristine—lymphatic system cancer	0.00214	0.00564	CcSEcCtD
Aminocaproic Acid—Pain—Fludarabine—lymphatic system cancer	0.00213	0.00564	CcSEcCtD
Aminocaproic Acid—Bradycardia—Mitoxantrone—lymphatic system cancer	0.00213	0.00562	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Teniposide—lymphatic system cancer	0.00209	0.00553	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00208	0.0055	CcSEcCtD
Aminocaproic Acid—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00207	0.00548	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00206	0.00543	CcSEcCtD
Aminocaproic Acid—Malaise—Bleomycin—lymphatic system cancer	0.00202	0.00534	CcSEcCtD
Aminocaproic Acid—Pruritus—Teniposide—lymphatic system cancer	0.00201	0.00531	CcSEcCtD
Aminocaproic Acid—Leukopenia—Bleomycin—lymphatic system cancer	0.00201	0.0053	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Teniposide—lymphatic system cancer	0.00194	0.00513	CcSEcCtD
Aminocaproic Acid—Myalgia—Bleomycin—lymphatic system cancer	0.00191	0.00504	CcSEcCtD
Aminocaproic Acid—Discomfort—Bleomycin—lymphatic system cancer	0.00189	0.00498	CcSEcCtD
Aminocaproic Acid—Confusional state—Bleomycin—lymphatic system cancer	0.00185	0.00488	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00184	0.00486	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Bleomycin—lymphatic system cancer	0.00183	0.00484	CcSEcCtD
Aminocaproic Acid—Oedema—Bleomycin—lymphatic system cancer	0.00183	0.00484	CcSEcCtD
Aminocaproic Acid—Vomiting—Teniposide—lymphatic system cancer	0.00181	0.00477	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Bleomycin—lymphatic system cancer	0.00179	0.00473	CcSEcCtD
Aminocaproic Acid—Rash—Teniposide—lymphatic system cancer	0.00179	0.00473	CcSEcCtD
Aminocaproic Acid—Dermatitis—Teniposide—lymphatic system cancer	0.00179	0.00473	CcSEcCtD
Aminocaproic Acid—Headache—Teniposide—lymphatic system cancer	0.00178	0.0047	CcSEcCtD
Aminocaproic Acid—Pruritus—Fludarabine—lymphatic system cancer	0.00177	0.00467	CcSEcCtD
Aminocaproic Acid—Leukopenia—Carmustine—lymphatic system cancer	0.00175	0.00463	CcSEcCtD
Aminocaproic Acid—Hypotension—Bleomycin—lymphatic system cancer	0.00171	0.00452	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Fludarabine—lymphatic system cancer	0.00171	0.00451	CcSEcCtD
Aminocaproic Acid—Convulsion—Carmustine—lymphatic system cancer	0.0017	0.00448	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00169	0.00446	CcSEcCtD
Aminocaproic Acid—Nausea—Teniposide—lymphatic system cancer	0.00169	0.00446	CcSEcCtD
Aminocaproic Acid—Leukopenia—Vincristine—lymphatic system cancer	0.00167	0.00442	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00167	0.00441	CcSEcCtD
Aminocaproic Acid—Myalgia—Carmustine—lymphatic system cancer	0.00167	0.0044	CcSEcCtD
Aminocaproic Acid—Malaise—Mitoxantrone—lymphatic system cancer	0.00164	0.00434	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Bleomycin—lymphatic system cancer	0.00163	0.00431	CcSEcCtD
Aminocaproic Acid—Leukopenia—Mitoxantrone—lymphatic system cancer	0.00163	0.0043	CcSEcCtD
Aminocaproic Acid—Convulsion—Vincristine—lymphatic system cancer	0.00162	0.00428	CcSEcCtD
Aminocaproic Acid—Confusional state—Carmustine—lymphatic system cancer	0.00161	0.00426	CcSEcCtD
Aminocaproic Acid—Oedema—Carmustine—lymphatic system cancer	0.0016	0.00422	CcSEcCtD
Aminocaproic Acid—Myalgia—Vincristine—lymphatic system cancer	0.00159	0.0042	CcSEcCtD
Aminocaproic Acid—Vomiting—Fludarabine—lymphatic system cancer	0.00159	0.00419	CcSEcCtD
Aminocaproic Acid—Convulsion—Mitoxantrone—lymphatic system cancer	0.00158	0.00417	CcSEcCtD
Aminocaproic Acid—Rash—Fludarabine—lymphatic system cancer	0.00157	0.00416	CcSEcCtD
Aminocaproic Acid—Dermatitis—Fludarabine—lymphatic system cancer	0.00157	0.00415	CcSEcCtD
Aminocaproic Acid—Pain—Bleomycin—lymphatic system cancer	0.00157	0.00414	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Carmustine—lymphatic system cancer	0.00156	0.00413	CcSEcCtD
Aminocaproic Acid—Headache—Fludarabine—lymphatic system cancer	0.00156	0.00413	CcSEcCtD
Aminocaproic Acid—Anaphylactoid reaction—Methotrexate—lymphatic system cancer	0.00156	0.00411	CcSEcCtD
Aminocaproic Acid—Myalgia—Mitoxantrone—lymphatic system cancer	0.00155	0.00409	CcSEcCtD
Aminocaproic Acid—Cerebrovascular accident—Methotrexate—lymphatic system cancer	0.00154	0.00406	CcSEcCtD
Aminocaproic Acid—Discomfort—Mitoxantrone—lymphatic system cancer	0.00153	0.00404	CcSEcCtD
Aminocaproic Acid—Oedema—Vincristine—lymphatic system cancer	0.00152	0.00403	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Vincristine—lymphatic system cancer	0.00152	0.00403	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00151	0.00398	CcSEcCtD
Aminocaproic Acid—Confusional state—Mitoxantrone—lymphatic system cancer	0.0015	0.00396	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Vincristine—lymphatic system cancer	0.00149	0.00395	CcSEcCtD
Aminocaproic Acid—Hypotension—Carmustine—lymphatic system cancer	0.00149	0.00394	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Mitoxantrone—lymphatic system cancer	0.00149	0.00392	CcSEcCtD
Aminocaproic Acid—Oedema—Mitoxantrone—lymphatic system cancer	0.00149	0.00392	CcSEcCtD
Aminocaproic Acid—Nausea—Fludarabine—lymphatic system cancer	0.00148	0.00392	CcSEcCtD
Aminocaproic Acid—Shock—Mitoxantrone—lymphatic system cancer	0.00146	0.00386	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00146	0.00385	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Mitoxantrone—lymphatic system cancer	0.00145	0.00384	CcSEcCtD
Aminocaproic Acid—Hypotension—Vincristine—lymphatic system cancer	0.00142	0.00377	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Carmustine—lymphatic system cancer	0.00142	0.00376	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.00139	0.00367	CcSEcCtD
Aminocaproic Acid—Hypotension—Mitoxantrone—lymphatic system cancer	0.00139	0.00367	CcSEcCtD
Aminocaproic Acid—Pain—Carmustine—lymphatic system cancer	0.00137	0.00361	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00135	0.00358	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00135	0.00356	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Mitoxantrone—lymphatic system cancer	0.00132	0.0035	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Carmustine—lymphatic system cancer	0.00132	0.00348	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.00131	0.00345	CcSEcCtD
Aminocaproic Acid—Pain—Vincristine—lymphatic system cancer	0.0013	0.00345	CcSEcCtD
Aminocaproic Acid—Pruritus—Bleomycin—lymphatic system cancer	0.00129	0.00342	CcSEcCtD
Aminocaproic Acid—Pain—Mitoxantrone—lymphatic system cancer	0.00127	0.00336	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Carmustine—lymphatic system cancer	0.00126	0.00334	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00125	0.00329	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00122	0.00323	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.00121	0.00321	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Vincristine—lymphatic system cancer	0.00121	0.00319	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Carmustine—lymphatic system cancer	0.00118	0.00311	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00117	0.0031	CcSEcCtD
Aminocaproic Acid—Vomiting—Bleomycin—lymphatic system cancer	0.00116	0.00307	CcSEcCtD
Aminocaproic Acid—Rash—Bleomycin—lymphatic system cancer	0.00115	0.00305	CcSEcCtD
Aminocaproic Acid—Dermatitis—Bleomycin—lymphatic system cancer	0.00115	0.00305	CcSEcCtD
Aminocaproic Acid—Renal failure—Methotrexate—lymphatic system cancer	0.00114	0.00301	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Vincristine—lymphatic system cancer	0.00112	0.00297	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00109	0.00289	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Carmustine—lymphatic system cancer	0.00109	0.00289	CcSEcCtD
Aminocaproic Acid—Nausea—Bleomycin—lymphatic system cancer	0.00109	0.00287	CcSEcCtD
Aminocaproic Acid—Agranulocytosis—Methotrexate—lymphatic system cancer	0.00108	0.00286	CcSEcCtD
Aminocaproic Acid—Dizziness—Carmustine—lymphatic system cancer	0.00106	0.00279	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Vincristine—lymphatic system cancer	0.00104	0.00276	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00102	0.00268	CcSEcCtD
Aminocaproic Acid—Vomiting—Carmustine—lymphatic system cancer	0.00102	0.00268	CcSEcCtD
Aminocaproic Acid—Dizziness—Vincristine—lymphatic system cancer	0.00101	0.00266	CcSEcCtD
Aminocaproic Acid—Rash—Carmustine—lymphatic system cancer	0.00101	0.00266	CcSEcCtD
Aminocaproic Acid—Dermatitis—Carmustine—lymphatic system cancer	0.00101	0.00266	CcSEcCtD
Aminocaproic Acid—Headache—Carmustine—lymphatic system cancer	0.001	0.00264	CcSEcCtD
Aminocaproic Acid—Tinnitus—Methotrexate—lymphatic system cancer	0.000971	0.00257	CcSEcCtD
Aminocaproic Acid—Vomiting—Vincristine—lymphatic system cancer	0.00097	0.00256	CcSEcCtD
Aminocaproic Acid—Rash—Vincristine—lymphatic system cancer	0.000962	0.00254	CcSEcCtD
Aminocaproic Acid—Dermatitis—Vincristine—lymphatic system cancer	0.000961	0.00254	CcSEcCtD
Aminocaproic Acid—Headache—Vincristine—lymphatic system cancer	0.000955	0.00252	CcSEcCtD
Aminocaproic Acid—Nausea—Carmustine—lymphatic system cancer	0.000949	0.00251	CcSEcCtD
Aminocaproic Acid—Vomiting—Mitoxantrone—lymphatic system cancer	0.000944	0.00249	CcSEcCtD
Aminocaproic Acid—Rash—Mitoxantrone—lymphatic system cancer	0.000936	0.00247	CcSEcCtD
Aminocaproic Acid—Dermatitis—Mitoxantrone—lymphatic system cancer	0.000936	0.00247	CcSEcCtD
Aminocaproic Acid—Headache—Mitoxantrone—lymphatic system cancer	0.00093	0.00246	CcSEcCtD
Aminocaproic Acid—Nausea—Vincristine—lymphatic system cancer	0.000906	0.00239	CcSEcCtD
Aminocaproic Acid—Nausea—Mitoxantrone—lymphatic system cancer	0.000882	0.00233	CcSEcCtD
Aminocaproic Acid—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000841	0.00222	CcSEcCtD
Aminocaproic Acid—Malaise—Methotrexate—lymphatic system cancer	0.000818	0.00216	CcSEcCtD
Aminocaproic Acid—Leukopenia—Methotrexate—lymphatic system cancer	0.000812	0.00214	CcSEcCtD
Aminocaproic Acid—Convulsion—Methotrexate—lymphatic system cancer	0.000786	0.00208	CcSEcCtD
Aminocaproic Acid—Myalgia—Methotrexate—lymphatic system cancer	0.000772	0.00204	CcSEcCtD
Aminocaproic Acid—Discomfort—Methotrexate—lymphatic system cancer	0.000763	0.00201	CcSEcCtD
Aminocaproic Acid—Confusional state—Methotrexate—lymphatic system cancer	0.000746	0.00197	CcSEcCtD
Aminocaproic Acid—Anaphylactic shock—Methotrexate—lymphatic system cancer	0.00074	0.00196	CcSEcCtD
Aminocaproic Acid—Thrombocytopenia—Methotrexate—lymphatic system cancer	0.000724	0.00191	CcSEcCtD
Aminocaproic Acid—Hypotension—Methotrexate—lymphatic system cancer	0.000691	0.00183	CcSEcCtD
Aminocaproic Acid—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000674	0.00178	CcSEcCtD
Aminocaproic Acid—Dyspnoea—Methotrexate—lymphatic system cancer	0.00066	0.00174	CcSEcCtD
Aminocaproic Acid—Pain—Methotrexate—lymphatic system cancer	0.000633	0.00167	CcSEcCtD
Aminocaproic Acid—Feeling abnormal—Methotrexate—lymphatic system cancer	0.00061	0.00161	CcSEcCtD
Aminocaproic Acid—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000605	0.0016	CcSEcCtD
Aminocaproic Acid—Abdominal pain—Methotrexate—lymphatic system cancer	0.000585	0.00155	CcSEcCtD
Aminocaproic Acid—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000545	0.00144	CcSEcCtD
Aminocaproic Acid—Pruritus—Methotrexate—lymphatic system cancer	0.000524	0.00138	CcSEcCtD
Aminocaproic Acid—Diarrhoea—Methotrexate—lymphatic system cancer	0.000506	0.00134	CcSEcCtD
Aminocaproic Acid—Dizziness—Methotrexate—lymphatic system cancer	0.000489	0.00129	CcSEcCtD
Aminocaproic Acid—Vomiting—Methotrexate—lymphatic system cancer	0.00047	0.00124	CcSEcCtD
Aminocaproic Acid—Rash—Methotrexate—lymphatic system cancer	0.000467	0.00123	CcSEcCtD
Aminocaproic Acid—Dermatitis—Methotrexate—lymphatic system cancer	0.000466	0.00123	CcSEcCtD
Aminocaproic Acid—Headache—Methotrexate—lymphatic system cancer	0.000464	0.00122	CcSEcCtD
Aminocaproic Acid—Nausea—Methotrexate—lymphatic system cancer	0.00044	0.00116	CcSEcCtD
